Your browser doesn't support javascript.
loading
Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró, Òscar; Galicia, Miguel; Dargan, Paul; Dines, Alison M; Giraudon, Isabelle; Heyerdahl, Fridtjof; Hovda, Knut E; Yates, Christopher; Wood, David M; Liakoni, Evangelia; Liechti, Matthias; Jürgens, Gesche; Pedersen, Carsten Boe; O'Connor, Niall; Markey, Gerard; Moughty, Adrian; Lee, Christopher; O'Donohoe, Patrick; Sein Anand, Jacek; Puiguriguer, Jordi; Homar, Catalina; Eyer, Florian; Vallersnes, Odd Martin; Persett, Per Sverre; Chevillard, Lucie; Mégarbane, Bruno; Paasma, Raido; Waring, W Stephen; Põld, Kristiina; Rabe, Christian; Kabata, Piotr Maciej.
Afiliação
  • Miró Ò; Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain.
  • Galicia M; Emergency Department, Hospital Clínic, IDIBAPS, University of Barcelona, Barcelona, Catalonia, Spain. Electronic address: mgalicia@clinic.cat.
  • Dargan P; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Dines AM; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK.
  • Giraudon I; European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Lisbon, Portugal.
  • Heyerdahl F; The National CBRNe Centre of Medicine, Department of Acute Medicine, Medical Division, Oslo University Hospital, Oslo, Norway.
  • Hovda KE; The National CBRNe Centre of Medicine, Department of Acute Medicine, Medical Division, Oslo University Hospital, Oslo, Norway.
  • Yates C; Emergency Department and Clinical Toxicology Unit, Hospital Universitari Son Espases, Mallorca, Spain.
  • Wood DM; Clinical Toxicology, Guy's and St Thomas' NHS Foundation Trust and King's Health Partners, London, UK; Clinical Toxicology, Faculty of Life Sciences and Medicine, King's College London, London, UK.
  • Liakoni E; Clinical Pharmacology and Toxicology, Department of General Internal Medicine, Inselspital, Bern University Hospital, University of Bern, Switzerland; Division of Clinical Pharmacology and Toxicology, Basel University Hospital and University of Basel, Switzerland.
  • Liechti M; Division of Clinical Pharmacology and Toxicology, Basel University Hospital and University of Basel, Switzerland.
  • Jürgens G; Zealand University Hospital Roskilde Clinical Pharmacology Unit Roskilde, Denmark.
  • Pedersen CB; Department of Anaesthesia University Hospital of Zealand, Køge, Denmark.
  • O'Connor N; Department of Emergency Medicine, Our Lady of Lourdes Hospital, Drogheda, County Louth, Republic of Ireland.
  • Markey G; Department of Emergency Medicine, Our Lady of Lourdes Hospital, Drogheda, County Louth, Republic of Ireland.
  • Moughty A; Emergency Department Mater Misericordiae University Hospital, Dublin 7, Republic of Ireland.
  • Lee C; Emergency Department Mater Misericordiae University Hospital, Dublin 7, Republic of Ireland.
  • O'Donohoe P; Emergency Department Mater Misericordiae University Hospital, Dublin 7, Republic of Ireland.
  • Sein Anand J; Department of Clinical Toxicology Medical University of Gdansk, Gdansk, Poland; Pomeranian Centre of Toxicology, Gdansk, Poland.
  • Puiguriguer J; Clinical Toxicology Unit Emergency Department, Hospital Son Espases, Palma de Mallorca, Balearic Island, Spain.
  • Homar C; Clinical Toxicology Unit Emergency Department, Hospital Son Espases, Palma de Mallorca, Balearic Island, Spain.
  • Eyer F; Department of Clinical Toxicology, Klinikum rechts der Isar, Technical University of Munich, Munich, Germany.
  • Vallersnes OM; Department of General Practice, University of Oslo, Oslo, Norway; Oslo Accident and Emergency Outpatient Clinic, City of Oslo Health Agency, Oslo, Norway.
  • Persett PS; Department of Acute Medicine, Medical Division, Oslo University Hospital, Oslo, Norway.
  • Chevillard L; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS-1144, Paris-Diderot University, Paris, France.
  • Mégarbane B; Department of Medical and Toxicological Critical Care, Lariboisière Hospital, INSERM UMRS-1144, Paris-Diderot University, Paris, France.
  • Paasma R; Foundation Pärnu Hospital, Pärnu, Estonia.
  • Waring WS; Acute Medical Unit York Teaching Hospitals NHS Foundation Trust York, UK.
  • Põld K; Emergency Medicine Department North-Estonia Medical Centre Tallinn, Estonia.
  • Rabe C; Department of Clinical Toxicology, Klinikum rechts der Isar, Technical University of Munich, Germany.
  • Kabata PM; Pomeranian Centre of Toxicology, Gdansk, Poland; Medical University Gdansk, Department of Clinical Toxicology, Gdansk, Poland.
Toxicol Lett ; 277: 84-91, 2017 Aug 05.
Article em En | MEDLINE | ID: mdl-28579487
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxibato de Sódio / 4-Butirolactona / Drogas Ilícitas / Transtornos Relacionados ao Uso de Substâncias / Overdose de Drogas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Toxicol Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Oxibato de Sódio / 4-Butirolactona / Drogas Ilícitas / Transtornos Relacionados ao Uso de Substâncias / Overdose de Drogas Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Europa Idioma: En Revista: Toxicol Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Espanha